CpG DNA as a vaccine adjuvant

References

• Field AK, Tytell AA, Lampson GP, Hilleman MR. Inducers of IFN and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl Acad. Sc]. 58,1004–1010 (1967).
   PubMed Web of Science ®Google Scholar
• Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS. Induction of antidouble stranded DNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol 142,1482–1486 (1989).
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Katoaka T, Yano O et al. Antitumor effect of nucleic acid fraction from bacteria. Proc. Jpn Soc. Immunol 48, 272–281 (1989).
   Google Scholar
• Yamamoto S, Yamamoto T, Shimada S et al. DNA from bacteria but not vertebrates, induces interferons, activate NK cells and inhibits tumor growth. Microbial. Immunol 36, 983–997 (1992).
   PubMed Web of Science ®Google Scholar
• Tho S, Yamamoto T, Takahashi T, Yamamoto S. Oligodeoxinucleotides containing palindrome sequences with internal 5 CpG-3- act directly on human NK and activated T-cells to induce IFN-y production in vitro j Immunol 163(7), 3642–3652 (1999).
   Google Scholar
• Yamamoto S, Yamamoto T, Katoaka T etal. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. hninunol. 148,4072–4076 (1992).
   Google Scholar
• Krieg AM, Yi A, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–548 (1995).
   PubMed Web of Science ®Google Scholar
• Cardon LR, Burge C, Clayton DA, Karlin S. Pervasive CpG suppression in animal mitochondrial genomes. Proc. Natl Acad. Sc]. USA 91,3799–3803 (1994).
   PubMed Web of Science ®Google Scholar
• Razin A, Friedman J. DNA methylation and its prKsible biological roles. Plug. Nucleic Acid Res. .11/b1. Biol. 25, 33–52 (1981).
   Google Scholar
• Rankin R, Pontarollo R, Ioannou X et al CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Add Drug Dev. 11(5), 333–340 (2001).
   Google Scholar
• Klinman DM, Yi A, Beaucage SL, Conover J, Krieg AM. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN-y. Proc. Nat! Acad. Sc]. USA 93,2879–2883 (1996).
   Google Scholar
• Halpern MD, Kurlander RJ, Pisetsky DS. Bacterial DNA induces murine interferon-gamma production by stimulation of IL-12 and tumor necrosis factor-alpha. Cell Immunol 167,72–78 (1996).
   Google Scholar
• Yi A-K, Hornbeck P, Lafrenz DE, Krieg AM. CpG DNA rescue of murine B lymphoma cells from antiIgIVI induced growth arrest and programmed cell death is associated with increased expression of c-myc and bd-xl. Immunology157,4918–4925 (1996).
   Google Scholar
• Bernasconi NL TELA. Maintenance of serological memory by polyclonal activation of human memory B-cells. Science 298(5601), 2199–2220 (2002).
   PubMed Web of Science ®Google Scholar
• Gursel M, Verthelyi D, Gursel I, Ishii KJ, Klinman DM. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotides. I Leukocyte Biol. 71,813–820 (2002).
   Google Scholar
• Medzhitov R, Janeway CA. Innate immunity: the virtues of a nonclonal system of recognition. Ce1191, 295–298 (1998).
   Google Scholar
• Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 406,782–787 (2000).
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterialDNA. Nature 408,740–745 (2000).
   PubMed Web of Science ®Google Scholar
• Takeshita F, Leifer CA, Gursel I et al Cutting Edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. humunol 167(7), 3555–3558 (2001).
   Google Scholar
• BauerS, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species specific CpG motif recognition. Proc. Nat! Acad. Sci. USA 98(16), 9237–9242 (2001).
   Google Scholar
• Yi A, Tuetken R, Redford T et al. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. I Immunol 160, 4755–4761 (1998).
   PubMed Web of Science ®Google Scholar
• Hacker H, Mischak H, Miethke T et al CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMI3017, 6230–6540 (1998).
   Google Scholar
• Hacker H, Vabulas RM, Takeuchi O et al Immune Cell Activation by Bacterial CpG-DNA through Myeroid Differentiation Marker 88 and Tumor Necrosis Factor Receptor-Associated Factor (TRAF)6. Exp. Med. 192,595-600 (2000).
   Google Scholar
• Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur j Immunol 32 (7), 1958–1968 (2002).
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259,1745–1749 (1993).
   PubMed Web of Science ®Google Scholar
• Fynan EF, Webster RG, Fuller DH et al. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Nat! Acad. Sci. USA 90, 11478–11482 (1993).
   PubMed Web of Science ®Google Scholar
• Sedegah M, Hedstrom R, Hobart P, Hoffman SL. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Nat! Acad. Sci. USA 91,9866–9870 (1994).
   PubMed Web of Science ®Google Scholar
• Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus Type 1. Proc. Nat! Acad. Sci. USA 90, 4156–4160 (1993).
   Google Scholar
• Wolff JA, Malone RVV, Williams P et al. Direct gene transfer into mouse musclein vivo. Science 247,1465–1468 (1990).
   PubMed Web of Science ®Google Scholar
• Manthorpe M, Cornefert JF, Hartildca J et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4,419–431 (1993).
   PubMed Web of Science ®Google Scholar
• Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. Viral 67,5664–5667 (1993).
   Google Scholar
• Klinman DM. Therapeutic applications of CpG-containing oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 8, 181–184 (1998).
   PubMedGoogle Scholar
• Mor G, Klinman DM, Shapiro S et al. Complexity of the cytokine and antibody response elicited by immunizing mice with Rasmodium yoelii circumsporozoite protein plasmid DNA. I Immunol 155, 2039–2046 (1995).
   PubMed Web of Science ®Google Scholar
• Sato Y, Roman M, Tighe H et al Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273,352–354 (1996).
   PubMed Web of Science ®Google Scholar
• Roman M, Martin-Orozco E, Goodman JS et al. Immunostimulatory DNA sequences function as T-helper-1 promoting adjuvants. Nat. Med. 3,849-854 (1997).
   Google Scholar
• Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol 158,3635–3642 (1997).
   Google Scholar
• Klinman DM, Barnhart KM, Conover J. CpG motifs as immune adjuvants. Vaccine 17,19–25 (1999).
   PubMed Web of Science ®Google Scholar
• Krieg AM, Wu T, Weeratna R etal. Sequence motifs in adenoviral DNA block immune activation by stimuatory CpG motifs. Proc. Nat/ Acad. Sci. 95,12631–12636 (1998).
   Google Scholar
• Krieg AM, Homan LL, Yi AK, Harty JT. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol 161, 2428–2434 (1998).
   Google Scholar
• Krieg AM, Davis HL. Enhancing vaccines with immune stimulatory CpG DNA. Gum Opin. Mal Ther. 3(1),15–24 (2001).
   Google Scholar
• Nur I, Szyf M, Razin A et al. Procaryotic and eucaryotic traits of DNA methylation in spiroplasmas (mycoplasmas). Bacterial. 164(1), 19–24 (1985).
   Google Scholar
• Yamada H, Gursel I, Takeshita F et al. Effect of suppressive DNA on CpG-induced immune activation. J. Immunol 169,5590–5594 (2002).
   PubMed Web of Science ®Google Scholar
• Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T-helper (Thl) immunity. I Exp. Med. 186,1623–1631 (1997).
   Google Scholar
• Lipford GB, Sparwasser T, Bauer M et al. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur. Immunol 27,3420–3426 (1997).
   PubMed Web of Science ®Google Scholar
• Weiner GJ, Liu HM, Wooldridge JE, Dahle CE, Krieg AM. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Nat! Acad. Sci. USA 94,10833–10837 (1997).
   Google Scholar
• Heinzel FP, Sadick MD, Mutha SS, Locksley RM. Production of IFN-y, IL-2, IL-4 and IL-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Nati Acad. Sc]. 88,7011-7015 (1991).
   Google Scholar
• Romain L, Mencacci A, Grohmann U et al. Neutralizing antibody to IL-4 induces systemic protection and Thl-associated immunity in murine candidiasis. J. Exp. Med. 176,115-123 (1992).
   Google Scholar
• Moldoveanu Z, Love-Homan L, Huang WQ, Krieg AM. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16,1216–1224 (1998).
   PubMed Web of Science ®Google Scholar
• Kovarik J, Bozzotti P, Love-Homan L et al. CpG oligonucleotides can cirmcuvent the Th2 polorization of neonatal responses to vaccines but fail to fully redirect Th2 responses established by neonatal priming. J. Immunol 162,1611–1617 (1999).
   Google Scholar
• McCluskie MJ, Davis HL. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. j Immunol 161, 4463–4466 (1998).
   PubMed Web of Science ®Google Scholar
• Brazolot Milan CL, Weeratna R, Krieg AM, Siegrist CA, Davis HL. CpG DNA can induce strong Thl humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Nati Acad. Sc]. USA 95 (26), 15553–15558 (1998).
   Google Scholar
• Eastcott JVV, Holmberg CJ, Dewhirst FE etal. Oligonudeotide containing CpG motifs enhances immune response to mucnsally or systemically administered tetanus toxoid. Vaccine 19(13-14), 1636–1642 (2001).
   PubMed Web of Science ®Google Scholar
• Branda RF, Moore AL, Lafayette AR et al Amplification of antibody production by phosphorothioate oligodeoxynucleotides. Lab. Clin. Med. 128,329–338 (1996).
   PubMed Web of Science ®Google Scholar
• Davis HL, Weeranta R, Waldschmidt TJ et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol 160,870–876 (1998).
   PubMed Web of Science ®Google Scholar
• Horner AA, Ronaghy A, Cheng PM et al Immunostimulatory DNA is a potent mucosal adjuvant. Cell Immunol 190, 77–82 (1998).
   PubMed Web of Science ®Google Scholar
• McCluskie MJ, Davis HL. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19(4-5), 413–422 (2000).
   PubMed Web of Science ®Google Scholar
• Sterzl J, Silverstein AM. Developmental aspects of immunity. Adv. Immunol 6, 337–459 (1967).
   PubMedGoogle Scholar
• Hunt DW, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: evidence for functional immaturity. B/ooc/ 84, 4333–4343 (1994).
   Google Scholar
• Pacifici R. Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 11(8), 1043–1051 (1996).
   Google Scholar
• Mor G, Yamshchikov G, Sedegah M et al. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin. Invest. 98,2700–2705 (1997).
   Web of Science ®Google Scholar
• Ishii KJ, Weiss WR, Klinman DM. Prevention of neonatal tolerance by aplasmid encoding GM-CSE Vaccine 18(7-8), 703–710 (1999).
   Google Scholar
• Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM. Human peripheral bloodcells differentially recognize and respond to two distinct CpG motifs. J Immunol 166, 2372–2377 (2001).
   Google Scholar
• Hartmann G, Weeratna RD, Ballas ZK et al. Delineation of a CpG phosphorothioate oligodeoxinucleotide for activating primate immune responses in vitro and in viva J Immunol 164, 1617–1624 (2000).
   Google Scholar
• Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B-cells. Immunol 164(1), 944–952 (2000).
   Google Scholar
• Verthelyi D, Kenney RT, Seder RA et al CpG oligodeoxynucleotides as vaccine adjuvants in primates. J. Immunol 168 (4), 1659–1663 (2002).
   PubMed Web of Science ®Google Scholar
• Davis HL, Suparto II, Weeratna RR et al. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine 19(4-5), 413–422 (2000).
   PubMed Web of Science ®Google Scholar
• Jones TR, Obaldia N, Gramzinski RA et al. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenic vaccine in Aotus monkeys. Vaccine 17(23-24), 3065–3071 (1999).
   PubMed Web of Science ®Google Scholar
• Amaral VF, Ransatto VAO, Conceicao-Solva F et al. Leishmarda amazonensis: The asian rhesus macaques (Macaca mulata) as an experimental model for the study of cutaneous leishmaniasis. Exp. Parasitol 82, 34–44 (1996).
   PubMed Web of Science ®Google Scholar
• Handman E. Leishmaniasis: Current status of vaccine development. Clin. Mcroboiol Rev 14(2), 229–243 (2001).
   PubMed Web of Science ®Google Scholar
• von Stebut E, Belkaid Y, Nguyen BV et al. Leishmania major infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis. Eur: Immunol 30,3498–3506 (2000).
   PubMed Web of Science ®Google Scholar
• Sparwasser T, Meithke T, Lipford G et al. Bacterial DNA causes septic shock. Nature 386,336–338 (1997).
   PubMed Web of Science ®Google Scholar
• Cowdery JS, Chace JH, Yi A-K, Krieg AM. Bacterial DNA induces NK cells to produce IFN-y in vivo and increases the toxicity of lipopolysaccharides. j Immunol 156, 4570–4575 (1996).
   Google Scholar
• Mor G, Singla M, Steinberg AD et al. Do DNA vaccines induce autoimmune disease? Hum. Gene firer 8,293–300 (1997).
   Web of Science ®Google Scholar
• Segal BM, Chang JT, Shevach EM. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalotogenic T-cells in vivo. J Immunol 164,5683–5688 (2000).
   Google Scholar
• Bachmaier K, Meu N, Maza LM et al. Chlamydia infections and heart disease linked through antigenic mimicry. Science 283,1335–1339 (1999).
   PubMed Web of Science ®Google Scholar
• Klinman DM, Taken° M, Ichino M et al. DNA vaccines: safety and efficacy issues. Springer Semin. Immunopathol 19, 245–256 (1997).
   Google Scholar
• Yi A, Klinman DM, Martin TL, Matson S, Krieg AM. Rapid immune activation by CpG motifs in bacterial DNA. J. Immunol 157,5394–5402 (1996).
   Google Scholar
• Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J. Immunol 157, 2116–2120 (1996).
   Google Scholar
• Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. Activation of cutaneous dendritic cells by CpG containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Thl responses by immunostimulatory DNA. J. Immunol 161,3042–3049 (1998).
   Google Scholar
• Sun S, Zhang X, Tough DF, Sprent J. Type I interferon-mediated stimulation of T-cells by CpG DNA. J. Exp. Med. 188, 2335–2342 (1998).
   PubMed Web of Science ®Google Scholar
• Sparwasser T, Miethke T, Lipford G et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-a-mediated shock. Eur. I Immunol 27, 1671–1679 (1997).
   PubMed Web of Science ®Google Scholar
• Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE. Activation of human B-cells by phosphorothioate oligodeoxynucleotides. j Clin. Invest. 98, 1119–1129 (1996).
   PubMed Web of Science ®Google Scholar
• Monteith DK, Henry SP, Howard RB et al. Immune stimulation — a class effect of phophorothioate oligodeoxynucleotides in rodents. Anticancer Drug- Design 12, 421–432 (1997).
   PubMedGoogle Scholar
• Hartmann G, Krug A, Waller K, Endres S. Oligodeoxynucleotides enhance LPS-stimulated synthesis of TNF-a dependence on phosphorothioate modification and reversal by heparin. ./1/b/. Med.. 2, 429–438 (1996).
   Google Scholar
• Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 272, 50–53 (1996).
   PubMed Web of Science ®Google Scholar
• Sparwasser T, Lipford GB. Consequences of bacterial CpG DNA-driven activation of antigen-presenting cells. Gun: Top. Microbial. Immunol 247, 59–76 (2000).
   Google Scholar
• Chiaramonte MG, Hesse M, Cheever AW, Wynn TA. CpG Oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg induced pathology by an IL-12 independent mechanism. j Immunol 164, 973–985 (2000).
   PubMed Web of Science ®Google Scholar
• Klinman DM, Verthelyi D, Takeshita F, Ishii KJ. Immune recognition of foreign DNA: a cure for bioterrorism? Immunity 11, 123–129 (1999).
   PubMed Web of Science ®Google Scholar